🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase I/II trial studies the safety and effectiveness of lenalidomide ...
Status
Completed
Location
University of Chicago
Start Date
2013-10-17
Trial ID
NCT01838434
Treatments Being Tested
This is a Phase 1/2, open-label, monocentric, dose-escalation study of lena...
Status
Unknown
Location
Medical University of Innsbruck, Department for Internal Medicine I
Start Date
2010-03
Trial ID
NCT01166035
Treatments Being Tested
Study Objectives 1. Evaluate the efficacy of the combination of thalidomid...
Status
Completed
Location
Weill Medical College of Cornell University
Start Date
2007-10
Trial ID
NCT00538733
Treatments Being Tested
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
The aim of this study is to determine the maximal tolerated dose level of l...
Status
Completed
Location
Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie
Start Date
2008-10
Trial ID
NCT00738829
Treatments Being Tested
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
Our hypothesis is that treating relapsed or refractory multiple myeloma wit...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2014-02
Trial ID
NCT02030483
Treatments Being Tested
The purpose of the study is to examine efficacy and safety of epcoritamab w...
Status
Terminated
Location
UW Cancer Center at ProHealth Care
Start Date
2023-03-06
Trial ID
NCT05660967
Treatments Being Tested
Primary Objective: To compare the complete response rate (CR rate) after in...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-23
Trial ID
NCT07505849
Treatments Being Tested
The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-06-12
Trial ID
NCT04181827
Treatments Being Tested